{"id":"W1944579984","doi":"10.1093/annonc/mdu342.3","title":"Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Pneumonitis; Internal medicine; Adverse effect; Melanoma; Common Terminology Criteria for Adverse Events; Oncology; Gastroenterology; Cancer; Immunotherapy; Cancer research; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001281084,0.001596763,0.002769523,0.0005636818,0.0006959202,0.001584048,0.001378819,0.001444133,0.002740771],"category_scores_gemma":[0.0007407781,0.0008520249,0.002039617,0.0005254143,0.001077165,0.0009430449,0.0004051483,0.00454783,0.001218201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00184086,"about_ca_system_score_gemma":0.002617062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003359135,"about_ca_topic_score_gemma":0.007381458,"domain_scores_codex":[0.9996126,0.0001386919,0.00001570794,0.00008193452,0.00003304398,0.0001180608],"domain_scores_gemma":[0.9994177,0.00007017463,0.00006987753,0.00005395773,0.00004346742,0.0003447604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6528915,0.1128378,0.006930484,0.001570049,0.003185597,0.0004491221,0.0006008614,0.005740256,0.06590886,0.0004460501,0.007047893,0.1423915],"study_design_scores_gemma":[0.4726156,0.5010094,0.01053247,0.00006329547,0.001042602,0.0003866351,0.0001460658,0.002148373,0.007342828,0.0002006944,0.004460829,0.00005118115],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901963,0.003801931,0.0005318663,0.0005968288,0.0002664781,0.001738248,0.0007591576,0.0001235949,0.001985443],"genre_scores_gemma":[0.9899085,0.002568757,0.00143659,0.0006042523,0.0001564779,0.001462874,0.00131474,0.00004529568,0.002502528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003359135,"threshold_uncertainty_score":0.01335645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05838712361830205,"score_gpt":0.3729663680209093,"score_spread":0.3145792444026072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}